Concepedia

Narinder Lotay

NL

Statistics

Publications

2

Citations

123

H-Index

2

Active since

2011

Affiliations

GlaxoSmithKline (United States)(Current)

GlaxoSmithKline (United Kingdom)

Research Triangle Park Foundation

Narinder Lotay is an author at GlaxoSmithKline (United States) specializing in antiepileptic pharmacology, antiepileptic pharmacotherapy, and open-label trials.

Publications per year

2011–2015

2

Publications

2

A Multi-Center Randomized Proof-of-Concept Clinical Trial Applying [18F]FDG-PET for Evaluation of Metabolic Therapy with Rosiglitazone XR in Mild to Moderate Alzheimer's Disease

Sofia Tzimopoulou, Vincent J. Cunningham, Thomas E. Nichols et al. · Journal of Alzheimer s Disease · 2011 · 109 citations

, , +5

Efficacy and safety of ezogabine/retigabine as adjunctive therapy to specified single antiepileptic medications in an open-label study of adults with partial-onset seizures

Holger Lerche, Jerzy Daniluk, Narinder Lotay et al. · Seizure · 2015 · 14 citations · Full text

, , +14

1–2 of 2